Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 July 2023 | Story Kekeletso Takang
UFS to host ABASA sixth annual Prof Wiseman Nkuhlu lecture

The University of the Free State (UFS) is pleased to host the Association for the Advancement of Black Accountants of Southern Africa’s (ABASA) sixth annual Wiseman Nkuhlu lecture on 28 July 2023 in the Equitas Auditorium on its Bloemfontein Campus.

The prestigious lecture will be delivered by Tantaswa Fubu, ABASA past President and CEO of Great Well, under the theme, The Value of Accountants Reimagined.

ABASA was established in 1985 to promote the professional interests of black persons engaged in the accounting profession. Through this lecture, the association aims to raise renewed support from ABASA stakeholders, captains of industry, and corporates to assist in providing the resources and expertise required for the university to continue producing the leadership excellence it is known and respected for.

Attendees can look forward to presentations by Prof Wiseman Nkuhlu, Chancellor of the University of Pretoria and Chairman of the Board of KPMG; Linda Maqoma, ABASA President; Dr Molapo Qhobela, a Deputy Vice-Chancellor at the UFS; Ayanda Mafuleka, CEO of Fasset; and Likeleli Monyamane, Programme Manager at Standard Bank Group.

The event will be attended by dignitaries from the UFS, SAICA, Fasset, and ABASA.

Event details:

Date:28 July 2023
Time:14:00-16:00
Venue:Equitas Auditorium
RSVP:communications@abasa.org.za

For more information, click here: https://ufsweb.co/3rzOORh

 


 

The prestigious lecture will be delivered by:

Tantaswa Fubu

Tantaswa Fubu was Group Executive: Human Capital and Transformation at Barloworld Limited, an industrial brand management company based in Sandton, South Africa. Fubu’s experience spans 30 years in diverse areas of the economy, including the banking, industrial, automotive, medical scheme, and mining sectors. At Barloworld, she was also instrumental in the integration of newly acquired businesses that performed exceptionally well in their first year; under her leadership, Barloworld was named among the overall Gender Mainstreaming Champions of 2020.

Fubu has worked for KPMG SA, where she was Executive Head: People (HR) and Transformation, and a member of the executive committee. She is a chartered accountant with qualifications in industrial psychology, accounting, banking, and finance.

She has also served as National President of the Association for the Advancement of Black Accountants of Southern Africa (ABASA). In addition, Fubu has previously worked for Standard Bank and Nkonki Inc, and serves as a non-executive director on several boards.

She is the founding CEO of Great Well, as well as a mentor and coach.

Bios of speakers:

Prof Wiseman Nkuhlu

Prof Wiseman Nkuhlu is the former Chancellor of the University of Pretoria and a member of the advisory board of the South African Institute of Chartered Accountants (SAICA).

Prof Nkuhlu served two terms as President of the South African Institute of Chartered Accountants, from April 1998 to April 2000. He is passionately involved with the development of black accountants and is the patron of the Nkuhlu School of Accounting at the University of Fort Hare.

He served as economic adviser to the President of the Republic of South Africa, TM Mbeki, and as chief executive of the secretariat of New Partnership for Africa’s Development (NEPAD) from 2000 to 2005, playing a major role in the elaboration of NEPAD policy framework and in promoting the programme both in Africa and internationally. He regularly participates as a speaker at international conferences on African development issues and corporate governance.

In recognition of his contribution to education, business, and development, Prof Nkuhlu has received a number of awards, including honorary doctorates from the University of the Free State, Stellenbosch University, the University of Cape Town, the University of Pretoria, Nelson Mandela Metropolitan University, the University of the Witwatersrand, and the University of Fort Hare; and merit awards from the National African Federated Chamber of Commerce, the Association for the Advancement of Black Accountants of Southern Africa, and the Black Management Forum. He was also awarded the President of Convocation Medal by the University of Cape Town in June 2004. The medal is awarded to graduates of UCT for outstanding community service.

Linda Maqoma

Linda Maqoma is the national president of ABASA, as well as the founding and chief executive of the Nomatshawe Group. Maqoma holds a BCom Accounting degree and Postgraduate Diploma in Accounting from the University of Fort Hare and has 11 years of experience in the audit space, both in the public and private sectors. She is the deputy chairperson of the Southern African Institute of Government Auditors (SAIGA) Africa and Global Committee, a member of the Black Business Council, National Council and Women's Alliance, Black Management Forum, as well as a member of the Black Business Women's Alliance steering committee.

With an inherent passion for business, people, and development, Maqoma is also an independent non-executive director of the Young African Entrepreneurs Institute, providing advice on the finance and fundraising portfolio. She is a candidate fellow of the fourth class of the Young African Leaders Initiative – South Africa (YALI), an extension of the Aspen Global Leadership Network fellowship. She has served as an audit manager in financial services at KPMG and as a success coach at SAPRO.

Dr Molapo Qhobela

Dr Qhobela holds a PhD in Plant Pathology from the Kansas State University in the United States of America. His career started at Rhodes University in 1991, where he was a lecturer in microbiology and pharmacy, after which he joined the University of Cape Town, before joining the public service sector. His leadership and strategic direction have been sought by several large and complex organisations in the course of his career. From 1998 to 2007, he was Chief Director: Higher Education Policy and Development Support in the Department of Education, from 2007 to 2009 he was Deputy Director General: Higher Education in the same department, and from 2010 to 2011 he was Deputy Director General: Human Capital and Knowledge Systems in the Department of Science and Technology.

Dr Qhobela was appointed Vice-Principal: Institutional Development at the University of South Africa (UNISA) in 2011 and held the position until 2015. He was the Chief Executive Officer of the National Research Foundation (NRF) from 2016 to 2020. 
Dr Qhobela has strong governance credentials, having served and led governing boards, among others as the former chairperson of the boards of the Agricultural Research Council, the Global Research Council, and the Committee of Heads of Organisations of Research and Technology (COHORT). He is currently the chairperson of the Tertiary Education and Research Network of South Africa (TENET).

Ayanda Mafuleka

Ayanda Mafuleka was appointed CEO of the Financial and Accounting Services Seta (FASSET) with effect from 1 January 2019. She previously served as the CFO of the state-owned coal mining company, African Exploration Mining and Finance Corporation (AEMFC). Prior to her AEMFC role, she was CFO at the National Credit Regulator. She has worked in finance across a diverse range of departments in government, including Transtel, the National Ports Authority, National Treasury, the Department of Home Affairs, and Johannesburg City Parks and Zoo. She holds a BCom Honours, Postgraduate Diploma in Forensic Auditing, and an LLB from UNISA.

Likeleli Monyamane

Monyamane sought to utilise the platform that her profession provided to serve her community. From her articles days, Monyamane served as a member of the Free State chapter of the Association for the Advancement of Black Accountants of Southern Africa (ABASA), rising through the ranks to become its first female chairperson. She also served as the youngest member of the University of the Free State Council, as well as on its audit and risk and finance committees.

She co-founded the Keep Lesotho Clean Campaign, which aims to solve Lesotho’s waste management challenges. The group hosts monthly clean-up campaigns and is planning to host a waste management conference and business and innovation challenges.

Monyamane is committed to the development of the accounting profession in Lesotho and has partnered with the Lesotho Institute of Accountants to host a number of development initiatives, such as a young accountant development workshop and a student leadership summit.

Monyamane is also a successful businesswoman who runs a professional services company in Lesotho – Inspire Innovation Business Consultants – with a number of leadership achievements, including the Mandela Washington Fellowship. She holds an MBA from the African Leadership University.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept